No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1ao6B, 1.0000, 0.00, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
2, 1bm0B, 0.9980, 0.23, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
3, 2esgC, 0.9972, 0.27, 1.000, 578, 192, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4, 1ao6A, 0.9972, 0.27, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
5, 1bm0A, 0.9960, 0.32, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
6, 3lu7B, 0.9940, 0.40, 1.000, 579, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
7, 4g03B, 0.9938, 0.41, 1.000, 578, 192, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
8, 4g04B, 0.9933, 0.43, 1.000, 578, 192, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
9, 3lu7A, 0.9932, 0.43, 1.000, 578, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 2
10, 4lb2A, 0.9928, 0.44, 1.000, 578, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
11, 4g03A, 0.9926, 0.45, 1.000, 578, 192, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
12, 4g04A, 0.9925, 0.45, 1.000, 578, 192, HIGH-RESOLUTION CRYSTAL STRUCTURAL VARIANCE ANALYSIS BETWEEN RECOMBINANT AND WILD-TYPE HUMAN SERUM ALBUMIN
13, 4la0A, 0.9922, 0.46, 1.000, 581, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
14, 2bxgA, 0.9922, 0.46, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
15, 4emxB, 0.9919, 0.47, 1.000, 579, 192, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
16, 2bxfA, 0.9919, 0.47, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
17, 4emxA, 0.9918, 0.47, 1.000, 581, 192, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN IN COMPLEX WITH CHLORIDE ANIONS AT CRYOGENIC TEMPERATURE
18, 2bx8A, 0.9918, 0.47, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
19, 2bxfB, 0.9917, 0.48, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM
20, 3lu8A, 0.9915, 0.49, 1.000, 578, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
21, 2bx8B, 0.9913, 0.50, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE
22, 2bxbB, 0.9912, 0.50, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
23, 4l9qA, 0.9911, 0.49, 1.000, 581, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
24, 3lu6B, 0.9911, 0.50, 1.000, 578, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
25, 2bxgB, 0.9911, 0.50, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN
26, 2bxcB, 0.9911, 0.50, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
27, 1e7bB, 0.9909, 0.50, 1.000, 576, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
28, 1e7aB, 0.9909, 0.51, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
29, 3lu6A, 0.9907, 0.51, 1.000, 578, 192, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 1
30, 4iw2A, 0.9906, 0.50, 1.000, 578, 192, HSA-GLUCOSE COMPLEX
31, 2bxhB, 0.9906, 0.51, 1.000, 557, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
32, 2bxdB, 0.9906, 0.52, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
33, 1e78B, 0.9904, 0.52, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
34, 2bxbA, 0.9902, 0.52, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE
35, 4la0B, 0.9901, 0.52, 1.000, 580, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH BICALUTAMIDE
36, 4l9qB, 0.9900, 0.53, 1.000, 578, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH TENIPOSIDE
37, 2bxhA, 0.9898, 0.53, 1.000, 557, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE
38, 2bxdA, 0.9898, 0.53, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN
39, 1e7aA, 0.9898, 0.53, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC PROPOFOL
40, 1e7bA, 0.9894, 0.55, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL ANESTHETIC HALOTHANE
41, 2bxcA, 0.9891, 0.55, 1.000, 578, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE
42, 1e78A, 0.9890, 0.55, 1.000, 578, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN
43, 4k2cB, 0.9886, 0.56, 1.000, 579, 192, HSA LIGAND FREE
44, 4lb2B, 0.9885, 0.56, 1.000, 578, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH IDARUBICIN
45, 4l9kA, 0.9881, 0.57, 1.000, 578, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
46, 5ujbB, 0.9874, 0.59, 1.000, 565, 192, STRUCTURE OF A MCL-1 INHIBITOR BINDING TO SITE 3 OF HUMAN SERUM ALBUMIN
47, 4k71A, 0.9871, 0.60, 1.000, 583, 192, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
48, 5fuoA, 0.9863, 0.61, 1.000, 578, 192, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
49, 5ujbA, 0.9840, 0.69, 1.000, 568, 192, STRUCTURE OF A MCL-1 INHIBITOR BINDING TO SITE 3 OF HUMAN SERUM ALBUMIN
50, 4l9kB, 0.9838, 0.68, 1.000, 578, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH CAMPTOTHECIN
51, 5x52A, 0.9828, 0.79, 1.000, 571, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTANOATE AND N-ACETYL-L-METHIONINE
52, 4k2cA, 0.9813, 0.72, 1.000, 579, 192, HSA LIGAND FREE
53, 5yoqA, 0.9744, 0.96, 1.000, 571, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH SODIUM 4-PHENYLBUTYRATE
54, 5x52B, 0.9698, 0.86, 1.000, 565, 190, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTANOATE AND N-ACETYL-L-METHIONINE
55, 4n0uD, 0.9698, 1.05, 1.000, 583, 192, TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR SERUM ALBUMIN AND FC
56, 3v09A, 0.9691, 1.10, 0.667, 583, 192, CRYSTAL STRUCTURE OF RABBIT SERUM ALBUMIN
57, 5id9A, 0.9669, 0.92, 0.754, 580, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
58, 4n0fJ, 0.9662, 1.09, 1.000, 583, 192, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
59, 4n0fG, 0.9660, 1.10, 1.000, 583, 192, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
60, 4n0fD, 0.9655, 1.10, 1.000, 583, 192, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
61, 4n0fM, 0.9651, 1.11, 1.000, 583, 192, HUMAN FCRN COMPLEXED WITH HUMAN SERUM ALBUMIN
62, 6ezqA, 0.9649, 0.64, 1.000, 563, 188, HUMAN SERUM ALBUMIN COMPLEXED WITH NBD-C12 FATTY ACID
63, 4k71D, 0.9641, 1.03, 1.000, 579, 192, CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
64, 5otbD, 0.9629, 1.03, 0.712, 581, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
65, 4or0A, 0.9625, 1.07, 0.707, 582, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
66, 4f5vA, 0.9625, 1.07, 0.644, 584, 191, CRYSTAL STRUCTURE OF LEPORINE SERUM ALBUMIN
67, 3lu8B, 0.9621, 0.62, 1.000, 573, 187, HUMAN SERUM ALBUMIN IN COMPLEX WITH COMPOUND 3
68, 4or0B, 0.9616, 1.08, 0.707, 582, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
69, 5yoqB, 0.9612, 0.74, 0.984, 563, 188, HUMAN SERUM ALBUMIN COMPLEXED WITH SODIUM 4-PHENYLBUTYRATE
70, 2bxiA, 0.9612, 1.13, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE
71, 4ot2A, 0.9609, 1.12, 0.754, 580, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
72, 5otbB, 0.9607, 1.06, 0.712, 581, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
73, 4zbrA, 0.9607, 1.13, 0.754, 580, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC AND NAPROXEN
74, 4f5sA, 0.9607, 1.09, 0.707, 583, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
75, 5dqfA, 0.9605, 1.11, 0.754, 580, 191, HORSE SERUM ALBUMIN (ESA) IN COMPLEX WITH CETIRIZINE
76, 2bxmA, 0.9603, 1.13, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN
77, 4f5tA, 0.9600, 1.11, 0.754, 583, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN
78, 3jryB, 0.9598, 1.58, 1.000, 575, 192, HUMAN SERUM ALBUMIN WITH BOUND SULFATE
79, 5otbA, 0.9597, 1.08, 0.712, 581, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
80, 5dbyA, 0.9597, 1.15, 0.754, 580, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC AND NAPROXEN OBTAINED IN DISPLACEMENT EXPERIMENT
81, 2bxkA, 0.9597, 1.14, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AZAPROPAZONE AND INDOMETHACIN
82, 5ijeA, 0.9595, 1.13, 0.754, 581, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 30 MM ZINC AT PH 7.4
83, 5vnwA, 0.9594, 1.16, 1.000, 583, 192, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
84, 4zbqA, 0.9594, 1.15, 0.754, 580, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH DICLOFENAC
85, 4hgkA, 0.9594, 0.78, 1.000, 483, 188, SHARK IGNAR VARIABLE DOMAIN
86, 3jryA, 0.9593, 1.59, 1.000, 575, 192, HUMAN SERUM ALBUMIN WITH BOUND SULFATE
87, 4lb9A, 0.9590, 1.15, 1.000, 583, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH ETOPOSIDE
88, 5otbC, 0.9589, 1.11, 0.712, 581, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN P1 SPACE GROUP
89, 4l8uA, 0.9587, 1.16, 1.000, 583, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH 9 AMINO CAMPTOTHECIN
90, 3jqzA, 0.9582, 1.21, 1.000, 582, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH LIDOCAINE
91, 4po0A, 0.9572, 1.16, 0.654, 583, 191, CRYSTAL STRUCTURE OF LEPORINE SERUM ALBUMIN IN COMPLEX WITH NAPROXEN
92, 5iiuA, 0.9568, 1.17, 0.754, 581, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 10 MM ZINC AT PH 6.9
93, 5orfC, 0.9567, 1.11, 0.717, 583, 191, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
94, 4f5sB, 0.9567, 1.15, 0.707, 583, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
95, 5iihA, 0.9566, 1.18, 0.754, 580, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 2.5 MM ZINC AT PH 7.4
96, 3v03A, 0.9560, 1.15, 0.707, 581, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
97, 4jk4B, 0.9559, 1.16, 0.707, 582, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
98, 3v03B, 0.9559, 1.15, 0.707, 579, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN
99, 5v0vA, 0.9554, 1.18, 0.754, 581, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN COMPLEX WITH ETODOLAC
100, 5oswA, 0.9551, 1.17, 0.712, 583, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN COMPLEX WITH 35-DIIODOSALICYLIC ACID
101, 2bxnA, 0.9548, 1.20, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE
102, 2bxqA, 0.9545, 1.21, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE PHENYLBUTAZONE AND INDOMETHACIN
103, 2i2zA, 0.9541, 1.22, 1.000, 581, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND ASPIRIN
104, 1ha2A, 0.9541, 1.21, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S- (-) ENANTIOMER OF WARFARIN
105, 4z69A, 0.9540, 1.22, 1.000, 581, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH PALMITIC ACID AND DICLOFENAC
106, 1e7eA, 0.9539, 1.21, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID (CAPRIC ACID)
107, 2xsiA, 0.9537, 1.22, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-GLUTAMATE AND MYRISTIC ACID
108, 5orfB, 0.9536, 1.19, 0.717, 583, 191, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
109, 2xvwA, 0.9536, 1.22, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ARGININE AND MYRISTIC ACID
110, 1h9zA, 0.9535, 1.23, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) ENANTIOMER OF WARFARIN
111, 4z69I, 0.9532, 1.22, 1.000, 581, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH PALMITIC ACID AND DICLOFENAC
112, 2i30A, 0.9531, 1.22, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND SALICYLIC ACID
113, 4jk4A, 0.9526, 1.19, 0.707, 582, 191, CRYSTAL STRUCTURE OF BOVINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
114, 2bxoA, 0.9526, 1.23, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE
115, 5vnwB, 0.9525, 1.24, 1.000, 581, 192, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
116, 4bkeA, 0.9522, 1.23, 1.000, 582, 192, RECOMBINANT HUMAN SERUM ALBUMIN WITH PALMITIC ACID. SYNTHETIC CATIONIC ANTIMICROBIAL PEPTIDES BIND WITH THEIR HYDROPHOBIC PARTS TO DRUG SITE II OF HUMAN SERUM ALBUMIN
117, 1gnjA, 0.9521, 1.24, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-581114-EICOSATETRAENOIC ACID (ARACHIDONIC ACID)
118, 2xvvA, 0.9520, 1.24, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE AND MYRISTIC ACID
119, 2bxpA, 0.9513, 1.25, 1.000, 581, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE
120, 1hk4A, 0.9511, 1.25, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
121, 4lufA, 0.9510, 1.23, 0.717, 583, 191, CRYSTAL STRUCTURE OF OVINE SERUM ALBUMIN
122, 5orfD, 0.9509, 1.24, 0.717, 583, 191, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
123, 1e7fA, 0.9508, 1.26, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID (LAURIC ACID)
124, 5oriA, 0.9502, 1.20, 0.712, 583, 191, STRUCTURE OF CAPRINE SERUM ALBUMIN IN ORTHORHOMBIC CRYSTAL SYSTEM
125, 3cx9A, 0.9498, 1.27, 1.000, 582, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND LYSOPHOSPHATIDYLETHANOLAMINE
126, 5ifoA, 0.9495, 1.27, 1.000, 582, 192, X-RAY STRUCTURE OF HSA-MYR-KP1019
127, 4luhA, 0.9495, 1.24, 0.717, 583, 191, COMPLEX OF OVINE SERUM ALBUMIN WITH 35-DIIODOSALICYLIC ACID
128, 5gixB, 0.9492, 1.28, 1.000, 581, 192, HUMAN SERUM ALBUMIN-PALMITIC ACID-FE(HN3PIT)CL2
129, 3sqjA, 0.9492, 1.27, 1.000, 582, 192, RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT
130, 1e7iA, 0.9492, 1.28, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID (STEARIC ACID)
131, 1e7hA, 0.9492, 1.28, 1.000, 581, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID (PALMITIC ACID)
132, 1n5uA, 0.9491, 1.28, 1.000, 583, 192, X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME
133, 3sqjB, 0.9490, 1.27, 1.000, 582, 192, RECOMBINANT HUMAN SERUM ALBUMIN FROM TRANSGENIC PLANT
134, 6ci6A, 0.9488, 1.28, 0.754, 581, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH NABUMETONE
135, 5ij5A, 0.9488, 1.27, 0.754, 581, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 50 MM ZINC AT PH 4.5
136, 3a73B, 0.9487, 1.28, 1.000, 576, 192, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
137, 3b9mA, 0.9485, 1.29, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE 3 -AZIDO-3 - DEOXYTHYMIDINE (AZT) AND SALICYLIC ACID
138, 2bxlA, 0.9484, 1.29, 1.000, 581, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 35- DIIODOSALICYLIC ACID
139, 1e7gA, 0.9481, 1.29, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID)
140, 5yxeA, 0.9479, 0.79, 0.774, 572, 186, CRYSTAL STRUCTURE ANALYSIS OF FELINE SERUM ALBUMIN
141, 5giyA, 0.9479, 1.30, 1.000, 581, 192, HSA-PALMITIC ACID-[RUCL5(IND)]2-
142, 5gixA, 0.9478, 1.30, 1.000, 581, 192, HUMAN SERUM ALBUMIN-PALMITIC ACID-FE(HN3PIT)CL2
143, 3tdlA, 0.9478, 1.30, 1.000, 578, 192, STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH DAUDA
144, 1e7cA, 0.9478, 1.29, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL ANESTHETIC HALOTHANE
145, 1bkeA, 0.9477, 1.29, 1.000, 581, 192, HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI- IODOBENZOIC ACID
146, 5id7B, 0.9476, 1.30, 1.000, 582, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
147, 1gniA, 0.9473, 1.30, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9-OCTADECENOIC ACID (OLEIC ACID)
148, 1bj5A, 0.9473, 1.30, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID
149, 2bxaA, 0.9472, 0.41, 1.000, 569, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF)
150, 2xw0A, 0.9469, 0.42, 1.000, 569, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
151, 2xvqA, 0.9469, 0.42, 1.000, 569, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
152, 2bxeA, 0.9469, 0.42, 1.000, 569, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
153, 5ijfA, 0.9468, 0.58, 1.000, 572, 184, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN THE PRESENCE OF 0.5 MM ZINC AT PH 9.0
154, 5id7A, 0.9465, 1.32, 1.000, 582, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN IN COMPLEX WITH PHOSPHORODITHIOATE DERIVATIVE OF MYRISTOYL CYCLIC PHOSPHATIDIC ACID (CPA)
155, 2xw1A, 0.9464, 0.44, 1.000, 569, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
156, 5orfA, 0.9462, 1.19, 0.684, 583, 190, STRUCTURE OF OVINE SERUM ALBUMIN IN P1 SPACE GROUP
157, 3b9lA, 0.9462, 1.31, 1.000, 582, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZT
158, 3jqzB, 0.9461, 1.34, 1.000, 582, 192, CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH LIDOCAINE
159, 3v08A, 0.9460, 1.33, 0.754, 581, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN
160, 2ydfA, 0.9459, 0.46, 1.000, 569, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
161, 4hgmB, 0.9454, 0.77, 0.978, 478, 185, SHARK IGNAR VARIABLE DOMAIN
162, 1hk5A, 0.9450, 1.33, 1.000, 582, 192, HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID)
163, 3uivA, 0.9449, 1.33, 1.000, 582, 192, HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
164, 2vufB, 0.9447, 0.49, 1.000, 549, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
165, 4hgkB, 0.9445, 0.63, 1.000, 481, 184, SHARK IGNAR VARIABLE DOMAIN
166, 2xvuA, 0.9445, 0.50, 1.000, 560, 183, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
167, 5iixA, 0.9440, 1.08, 0.754, 577, 187, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN THE PRESENCE OF 15 MM ZINC AT PH 6.5
168, 3uivH, 0.9424, 1.35, 1.000, 582, 192, HUMAN SERUM ALBUMIN-MYRISTATE-AMANTADINE HYDROCHLORIDE COMPLEX
169, 3a73A, 0.9423, 1.36, 1.000, 576, 192, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SERUM ALBUMIN COMPLEXED WITH DELTA 12-PROSTAGLANDIN J2
170, 2vueA, 0.9414, 0.43, 1.000, 565, 182, HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z15E-BILIRUBIN-IX- ALPHA
171, 1o9xA, 0.9409, 1.37, 1.000, 579, 192, HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC ACID) AND HEMIN
172, 2xvuB, 0.9404, 0.46, 1.000, 557, 182, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-ASPARAGINE
173, 2vufA, 0.9401, 0.47, 1.000, 556, 182, HUMAN SERUM ALBUMIN COMPLEXED WITH FUSIDIC ACID
174, 1hk1A, 0.9314, 0.42, 1.000, 553, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
175, 1hk3A, 0.9313, 0.42, 1.000, 559, 180, HUMAN SERUM ALBUMIN MUTANT R218P COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
176, 1hk2A, 0.9310, 0.43, 1.000, 560, 180, HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (33 55 -TETRAIODO-L-THYRONINE)
177, 4s1yA, 0.9307, 0.44, 1.000, 543, 180, X-RAY STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH CISPLATIN
178, 2ydfB, 0.9304, 0.46, 1.000, 566, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH IOPHENOXIC ACID
179, 2bxaB, 0.9299, 0.48, 1.000, 566, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY-4-METHYL-5- PROPYL-2-FURANPROPANOIC ACID (CMPF)
180, 2xw1B, 0.9298, 0.48, 1.000, 566, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-NORVALINE
181, 2xvqB, 0.9298, 0.48, 1.000, 566, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-SARCOSINE
182, 2xw0B, 0.9297, 0.48, 1.000, 566, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DANSYL-L-PHENYLALANINE
183, 2bxeB, 0.9296, 0.49, 1.000, 566, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL
184, 4f5uA, 0.9269, 1.53, 0.754, 583, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN AT 2.04 RESOLUTION
185, 4iw1A, 0.9259, 0.58, 1.000, 560, 180, HSA-FRUCTOSE COMPLEX
186, 2vueB, 0.9259, 0.60, 1.000, 559, 180, HUMAN SERUM ALBUMIN COMPLEXED WITH 4Z15E-BILIRUBIN-IX- ALPHA
187, 4j2vA, 0.9258, 1.55, 0.754, 581, 191, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN IN COMPLEX WITH 35- DIIODOSALICYLIC ACID
188, 2vdbA, 0.9243, 1.19, 0.984, 574, 186, STRUCTURE OF HUMAN SERUM ALBUMIN WITH S-NAPROXEN AND THE GA MODULE
189, 1tf0A, 0.9165, 0.80, 1.000, 556, 180, CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMAN SERUM ALBUMIN
190, 5hozA, 0.9148, 1.12, 0.747, 572, 182, CRYSTAL STRUCTURE OF EQUINE SERUM ALBUMIN (ESA) AT PH 9.0
191, 1uorA, 0.9118, 1.65, 0.810, 580, 189, X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED BY MOLECULAR REPLACEMENT METHOD USING LOW RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN
192, 4e99A, 0.9002, 0.99, 1.000, 554, 179, HUMAN SERUM ALBUMIN COMPLEX WITH PERFLUOROOCTANE SULFONATE POTASSIUM
193, 5ghkA, 0.8902, 0.92, 0.744, 563, 176, CRYSTAL STRUCTURE ANALYSIS OF CANINE SERUM ALBUMIN
194, 5oklB, 0.7836, 2.26, 0.302, 558, 169, HUMAN AFAMIN MONOCLINIC CRYSTAL FORM
195, 5oklA, 0.7566, 3.26, 0.175, 561, 183, HUMAN AFAMIN MONOCLINIC CRYSTAL FORM
196, 1kw2A, 0.7470, 3.38, 0.215, 455, 186, CRYSTAL STRUCTURE OF UNCOMPLEXED VITAMIN D-BINDING PROTEIN
197, 1kw2B, 0.7413, 3.44, 0.220, 453, 186, CRYSTAL STRUCTURE OF UNCOMPLEXED VITAMIN D-BINDING PROTEIN
198, 1j78B, 0.7332, 3.51, 0.207, 447, 184, CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN VITAMIN D BINDING PROTEIN
199, 1j7eB, 0.7320, 3.34, 0.198, 447, 182, A STRUCTURAL BASIS FOR THE UNIQUE BINDING FEATURES OF THE HUMAN VITAMIN D-BINDING PROTEIN
200, 1ma9A, 0.7253, 3.48, 0.202, 442, 183, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN VITAMIN D BINDING PROTEIN AND RABBIT MUSCLE ACTIN
201, 1kxpD, 0.7165, 3.39, 0.194, 438, 180, CRYSTAL STRUCTURE OF HUMAN VITAMIN D-BINDING PROTEIN IN COMPLEX WITH SKELETAL ACTIN
202, 1lotA, 0.7063, 3.53, 0.193, 436, 181, CRYSTAL STRUCTURE OF THE COMPLEX OF ACTIN WITH VITAMIN D-BINDING PROTEIN
203, 1j78A, 0.7035, 3.35, 0.223, 433, 175, CRYSTALLOGRAPHIC ANALYSIS OF THE HUMAN VITAMIN D BINDING PROTEIN
204, 1j7eA, 0.6958, 3.40, 0.227, 435, 176, A STRUCTURAL BASIS FOR THE UNIQUE BINDING FEATURES OF THE HUMAN VITAMIN D-BINDING PROTEIN
205, 1ysxA, 0.6392, 3.86, 0.123, 200, 171, SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMIN COMPLEXED TO AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL- XL AND BCL-2
